Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Shengyuan Stem Cell Technology is a biotechnology company based in Nantong, China, specializing in the research, development, and clinical application of stem cell technologies. The company operates a comprehensive stem cell bank and focuses on the therapeutic potential of mesenchymal stem cells for regenerative medicine. Its services include stem cell storage, technical consulting, and the development of cell-based therapies for various degenerative and inflammatory conditions. Nantong Shengyuan collaborates with academic and clinical institutions to advance its pipeline, which includes treatments for osteoarthritis and liver disease. The company maintains a GMP-compliant facility to ensure the production of high-quality, clinical-grade cell products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Shengyuan Stem Cell Technology.